Clinical research

A novel approach to the management of occlusive in-stent restenosis (ISR)

EuroIntervention 2014;9:1285-1293. DOI: 10.4244/EIJV9I11A218

William M. Wilson
William M. Wilson1, MBBS, FRACP; Simon Walsh3, MD, FRCP; Colm Hanratty3, MD, FRCPI; Julian Strange4, MBChB, FRCP, MD; Jonathan Hill5, MA, MBChB, MRCP; James Sapontis5, MBBCh, BSc, FRACP; James C Spratt1,2*, BSc, MD, FRCP, FESC, FACC
1. Edinburgh Heart Centre, Little France, Edinburgh, Scotland, United Kingdom; 2. Forth Valley Royal Hospital, Larbert, Scotland, United Kingdom; 3. Belfast Health and Social Care Trust, Northern Ireland, United Kingdom; 4. Bristol Heart Institute, Bristo

Aims: Chronic total occlusions (CTO) secondary to in-stent restenosis (ISR) represent challenging lesions with low PCI success rates. The CrossBoss is an over-the-wire blunt catheter whic

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

chronic total occlusioncrossboss catheterin-stent restenosis
Read next article
A prospective registry on carotid artery revascularisation selected by consensus of a cardiovascular team

Latest news